Global Microbiology Market to See Enhanced Level of Automation, According to VPG Research Report Now Available at MarketPublishers.com
14 Feb 2017 • by Natalie Aster
LONDON – Over the past few years, the degree of automation in such clinical laboratory segment as microbiology has been trailing behind, as opposed to hematology and chemistry laboratories. The slow-paced acceptance of the technology is in some degree lies in the complexity and intricacy of developing automated tests in microbiology lab settings. The launch of automated instrumentation for microbiology testing has been held back by a range of deep-seated and technical issues. The spread of automated microbiological test systems, once the technology was developed, has not lined up with that of other automated lab technologies. The acquisition of automation in microbiology labs has been detained by factors less readily detectable than the effects of different reimbursement plans. Some lab technicians keep on believing that today’s instrumentation is not the latest technology and look forward to enhanced automation heaving in sight.
The factor driving the need for fast reporting of microbiology test results is the clinical significance in a period of financial austerity, a time when healthcare and cost effectiveness to the diagnostician and patient looms ever larger, and where after-the-fact results at high cost are being brought under severe scrutiny all over the world.
In-demand report “2017 World Automated Microbiology Market” elaborated by VPG provides an in-depth assessment of the market globally with a detailed focus on the 75 country markets.
The study is aimed at identifying and evaluating emerging opportunities in the market for automated microbiology solutions over the next 5 years.
The research report sheds light on key trends in the marketplace; gives an all-round overview of the existing and emerging assays; reviews major automated systems. The study assesses prospective application areas for innovative diagnostic technologies in the microbiology marketplace, and reviews firms developing or marketing microbiology products, based on individual test. The report presents detailed projections of volume and sales for 100 microbial identification, molecular diagnostic, blood culture, urine screening, antibiotic susceptibility, and immunodiagnostic procedures. The report provides profiles of the prominent players as well as potential entrants to the market. In also gives information on emerging opportunities, alternative market penetration strategies. A review of the potential market entry barriers and risks is included.
More insightful studies by the publisher can be found at VPG page.